Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SSX8 Antikörper (C-Term)

SSX8 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN928571
  • Target Alle SSX8 Produkte
    SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))
    Bindungsspezifität
    • 15
    • 1
    C-Term
    Reaktivität
    • 15
    • 2
    Human
    Wirt
    • 17
    Kaninchen
    Klonalität
    • 17
    Polyklonal
    Konjugat
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser SSX8 Antikörper ist unkonjugiert
    Applikation
    • 17
    • 13
    • 13
    • 4
    • 3
    • 3
    Western Blotting (WB)
    Aufreinigung
    Purified
    Immunogen
    SSX8 antibody was raised in rabbit using the C terminal of SSX8 as the immunogen
  • Applikationshinweise
    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    SSX8 Blocking Peptide, catalog no. 33R-6543, is also available for use as a blocking control in assays to test for specificity of this SSX8 antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Konzentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Target
    SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))
    Andere Bezeichnung
    SSX8 (SSX8 Produkte)
    Synonyme
    SSX family member 8, pseudogene antikoerper, SSX8 antikoerper
    Hintergrund
    SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. Synonyms: Polyclonal SSX8 antibody, Anti-SSX8 antibody, synovial sarcoma, X breakpoint 8 antibody.
Sie sind hier:
Kundenservice